Document is current
Any future updates will be listed below
-
Authors
Richter, Maike https://orcid.org/0000-0003-4078-3954
Emden, Daniel
Leenings, Ramona
Winter, Nils R.
Mikolajczyk, Rafael
Massag, Janka
Zwiky, Esther https://orcid.org/0000-0002-6733-8087
Borgers, Tiana
Redlich, Ronny https://orcid.org/0000-0002-7018-4525
Koutsouleris, Nikolaos https://orcid.org/0000-0001-6825-6262
Falguera, Renata
Edwin Thanarajah, Sharmili
Padberg, Frank https://orcid.org/0000-0001-7638-8310
Reinhard, Matthias A.
Back, Mitja D. https://orcid.org/0000-0003-2186-1558
Morina, Nexhmedin https://orcid.org/0000-0002-2331-9140
Buhlmann, Ulrike
Kircher, Tilo https://orcid.org/0000-0002-2514-2625
Dannlowski, Udo https://orcid.org/0000-0002-0623-3759
,
Ratzsch, Janette
Blitz, Rogério
Köhler, Lena Florentine
Rau, Moritz
,
Thiel, Katharina
Flinkenflügel, Kira
Schürmeyer, Navid
Kraus, Anna
Goltermann, Janik
Nenadic, Igor
Straube, Benjamin
Alexander, Nina
Jamalabadi, Hamidreza
Jansen, Andreas
Stein, Frederike
Thomas-Odenthal, Florian
Usemann, Paula
Teutenberg, Lea
Brosch, Katharina
Meinert, Susanne
,
Brambilla, Paolo
Upthegrove, Rachel
Fabbro, Franco
Salonkangas, Raimo K. R.
Kambeitz, Joseph
Borgwardt, Stefan
Meisenzahl-Lechner, Eva
Bertolino, Alessandro
Lencer, Rebekka
Hahn, Tim https://orcid.org/0000-0001-6541-3795
Opel, Nils https://orcid.org/0000-0003-4749-3298
- License Information
-
More Information
Article History
Received: 12 September 2024
Revised: 4 February 2025
Accepted: 6 March 2025
First Online: 19 March 2025
Competing interests
: FP is a member of the European Scientific Advisory Board of Brainsway Inc., Jerusalem, Israel, and the International Scientific Advisory Board of Sooma, Helsinki, Finland. He has received speaker’s honoraria from Mag&More GmbH and the neuroCare Group. His lab has received support with equipment from neuroConn GmbH, Ilmenau, Germany, and Mag&More GmbH and Brainsway Inc., Jerusalem, Israel. MAR has received financial research support from the EU (H2020 No. 754740) and served as PI in clinical trials from Abide Therapeutics, Böhringer-Ingelheim, Emalex Biosciences, Lundbeck GmbH, Nuvelution TS Pharma Inc., Oryzon, Otsuka Pharmaceuticals and Therapix Biosciences. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
: Written informed consent was obtained from all participants of this study.
: The research in all samples was conducted ethically in accordance with the World Medical Association Declaration of Helsinki and approved by all samples’ local institutional review boards and ethics committees named hereafter: • Ethikkommission beider Basel (EKBB), • Klinisches Ethikkomitee der Universitären Psychiatrischen Kliniken Basel (KLINEK UPK), • Ethics Commission of the Westphalia-Lippe Medical Association and the University of Münster, • Ethics Committee of the Faculty of Psychology and Sports Science at the University of Münster, • Ethics Commission of the Faculty of Medicine at the University of Münster, • Ethics Commission of the Faculty of Medicine at the Philipps-University Marburg, • Ethics Commission of the Faculty of Medicine of Friedrich-Schiller-University Jena, • Ethics Commission of the Faculty of Medicine at Ludwig-Maximilians-University Munich, • Ethics Commission of the Faculty of Medicine at Martin-Luther-University Halle-Wittenberg, • Kommission für ethische Fragen der Wissenschaft der Martin-Luther-Universität Halle-Wittenberg (KeFW), • Ethics Commission of the Faculty of Medicine of Cologne University, • Ethics Committee of the Medical Faculty at Heinrich Heine University of Düsseldorf, • Ethics Commission of the University of Turku, • Independent Ethical Committee of the University of Bari Aldo Moro (Il Comitato Etico), • Departmental Commission for the Experimentation and Protection of the Person of the Department of Medicine of the University of Udine (IRB-DMED), • Ethics Committee of the University of Milan, • Ethics Committee of the University of Birmingham.
